Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Metabolic alterations and vulnerabilities in hepatocellular carcinoma
Daniel G. Tenen, Li Chai, Justin L. Tan
Gastroenterology report (2020) Vol. 9, Iss. 1, pp. 1-13
Open Access | Times Cited: 52

Showing 1-25 of 52 citing articles:

The Role of Fatty Acids in Non-Alcoholic Fatty Liver Disease Progression: An Update
Aleksandra Hliwa, Bruno Ramos‐Molina, Dariusz Łaski, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 13, pp. 6900-6900
Open Access | Times Cited: 55
Nanoplastics Toxicity Specific to Liver in Inducing Metabolic Dysfunction—A Comprehensive Review
Shoumi Haldar, Nounenuo Yhome, Yuvashree Muralidaran, et al.
Genes (2023) Vol. 14, Iss. 3, pp. 590-590
Open Access | Times Cited: 28
Metabolic Reprogramming of HCC: A New Microenvironment for Immune Responses
Beatrice Foglia, Marc Beltrà, Salvatore Sutti, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7463-7463
Open Access | Times Cited: 28
Experimental Models of Hepatocellular Carcinoma—A Preclinical Perspective
Alexandru Blidişel, Iasmina Marcovici, Dorina Coricovac, et al.
Cancers (2021) Vol. 13, Iss. 15, pp. 3651-3651
Open Access | Times Cited: 54
The NADPH oxidase NOX4 regulates redox and metabolic homeostasis preventing HCC progression
Irene Peñuelas‐Haro, Rut Espinosa‐Sotelo, Eva Crosas‐Molist, et al.
Hepatology (2022) Vol. 78, Iss. 2, pp. 416-433
Open Access | Times Cited: 30
Why may citrate sodium significantly increase the effectiveness of transarterial chemoembolization in hepatocellular carcinoma?
Philippe Icard, Luca Simula, Zherui Wu, et al.
Drug Resistance Updates (2021) Vol. 59, pp. 100790-100790
Open Access | Times Cited: 34
Molecular Targets and Signaling Pathways of microRNA-122 in Hepatocellular Carcinoma
Kwang‐Hoon Chun
Pharmaceutics (2022) Vol. 14, Iss. 7, pp. 1380-1380
Open Access | Times Cited: 25
The altered lipidome of hepatocellular carcinoma
Shawn Lu Wen Tan, Erez Israeli, Russell Ericksen, et al.
Seminars in Cancer Biology (2022) Vol. 86, pp. 445-456
Closed Access | Times Cited: 24
Multiomics profiling of buffy coat and plasma unveils etiology-specific signatures in hepatocellular carcinoma
Jiwon Hong, Jung Woo Eun, Geum Ok Baek, et al.
Clinical and Molecular Hepatology (2024) Vol. 30, Iss. 3, pp. 360-374
Open Access | Times Cited: 4
Exploring the multi-targeting phytoestrogen potential of Calycosin for cancer treatment: A review
Fangbing Ren, Yanhui Ma, Kexin Zhang, et al.
Medicine (2024) Vol. 103, Iss. 18, pp. e38023-e38023
Open Access | Times Cited: 4
Bioinformatics‐based identification of hepatocellular carcinoma‐associated hub genes and assessment of the restorative effect of tannic acid in rat liver exposed to monosodium glutamate
Hilal Tosun, Habibe Karadaş, Hamid Ceylan
Cancer Medicine (2024) Vol. 13, Iss. 12
Open Access | Times Cited: 4
PYCR1 promotes liver cancer cell growth and metastasis by regulating IRS1 expression through lactylation modification
Haoyu Wang, Mu Xu, Tong Zhang, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 10
Open Access | Times Cited: 4
Succinate Supplementation alleviates liver cancer by inhibiting the FN1/SQLE axis-mediated cholesterol biosynthesis
S. Laura Chang, Akiko Tomii, Yunfei Zhou, et al.
iScience (2025) Vol. 28, Iss. 2, pp. 111731-111731
Open Access
MAGI2-AS3/miR-450b-5p/COLEC10 Interaction Network: A Potential Therapeutic and Prognostic Marker in Hepatocellular Carcinoma
Lan‐Qing Yao, Yong‐Kang Diao, Jiaxiang Gong, et al.
iLiver (2025), pp. 100146-100146
Open Access
Metabolic reprogramming in hepatocellular carcinoma: mechanisms and therapeutic implications
Sujin Park, Michael N. Hall
Experimental & Molecular Medicine (2025)
Open Access
Metabolomics and Lipidomics Screening Reveal Reprogrammed Signaling Pathways toward Cancer Development in Non-Alcoholic Steatohepatitis
Eman Ahmed, Marwa O. El-Derany, Ali Mostafa Anwar, et al.
International Journal of Molecular Sciences (2022) Vol. 24, Iss. 1, pp. 210-210
Open Access | Times Cited: 20
CTpathway: a CrossTalk-based pathway enrichment analysis method for cancer research
Haizhou Liu, Mengqin Yuan, Ramkrishna Mitra, et al.
Genome Medicine (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 19
Glutamine metabolic reprogramming in hepatocellular carcinoma
Yanyan Ye, Bodong Yu, Hua Wang, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 11
A Gene Co-Expression Network-Based Drug Repositioning Approach Identifies Candidates for Treatment of Hepatocellular Carcinoma
Meng Yuan, Ko Eun Shong, Xiangyu Li, et al.
Cancers (2022) Vol. 14, Iss. 6, pp. 1573-1573
Open Access | Times Cited: 18
Crosstalk between Epigenetics and Metabolic Reprogramming in Metabolic Dysfunction-Associated Steatotic Liver Disease-Induced Hepatocellular Carcinoma: A New Sight
Anqi Li, Rui Wang, Yu-Qiang Zhao, et al.
Metabolites (2024) Vol. 14, Iss. 6, pp. 325-325
Open Access | Times Cited: 3
DNA methylation and gene expression profiling reveal potential association of retinol metabolism related genes with hepatocellular carcinoma development
Yanteng Zhao, Kangkang Wan, Jing Wang, et al.
PeerJ (2024) Vol. 12, pp. e17916-e17916
Open Access | Times Cited: 3
PFKFB3-mediated Pro-glycolytic Shift in Hepatocellular Carcinoma Proliferation
Qianhui Dou, Aaron K. Grant, Cody Callahan, et al.
Cellular and Molecular Gastroenterology and Hepatology (2022) Vol. 15, Iss. 1, pp. 61-75
Open Access | Times Cited: 14
Evaluating the impact of PD-1 inhibitor treatment on key health outcomes for cancer patients in China
Pei Zhang, Lingli Zhang, Kai Xu, et al.
International Journal of Clinical Pharmacy (2024) Vol. 46, Iss. 2, pp. 429-438
Closed Access | Times Cited: 2
Characterizing Metabolic Heterogeneity of Hepatocellular Carcinoma with Hyperpolarized 13C Pyruvate MRI and Mass Spectrometry
Qianhui Dou, Aaron K. Grant, Patricia Coutinto de Souza, et al.
Radiology Imaging Cancer (2024) Vol. 6, Iss. 2
Open Access | Times Cited: 2
MAGMa: Your Comprehensive Tool for Differential Expression Analysis in Mass-Spectrometry Proteomic Data.
Shagun Gupta, Jin Joo Kang, Yu Sun, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top